Secure and efficacious therapy delivery for an extra-systolic stimulation pacing engine

• US 7,233,824 B2
• Filed: 11/07/2003
• Issued: 06/19/2007
• Est. Priority Date: 10/07/2003
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Gillberg, Jeffrey M., Kleckner, Karen J., Deno, D. Curtis, Zillmer, Glenn C., Zhou, Ren, Anderson, Kenneth M., Splett, Vincent E., Prieve, Kathleen A., Klepfer, Ruth N.
• Primary Examiner(s): Layno; Carl
• Assistant Examiner(s): Heller; Tammie K.
• Application Number:
  US10/703,956
• Publication Number:
  US 20050101998A1
• Time in Patent Office: 1,320 Days
• Field of Search: 607/9, 607/11, 607/14, 607/15
• US Class Current: 607/11
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance
• CPC Class Codes: A61N 1/36564 controlled by blood pressure
• CPC Class Codes: A61N 1/36578 controlled by mechanical motion of the heart wall, e.g. measured by an accelerometer or microphone
• CPC Class Codes: A61N 1/36585 controlled by two or more physical parameters
• CPC Class Codes: A61N 1/3684 for stimulating the heart at multiple sites of the ventricle or the atrium
• CPC Class Codes: A61N 1/36842 Multi-site stimulation in the same chamber
• CPC Class Codes: A61N 1/36843 Bi-ventricular stimulation

Abstract

An extra-systolic stimulation (ESS) therapy addresses cardiac dysfunction including heart failure. ESS therapy employs atrial and/or ventricular extra-systoles via pacing-level stimulation to a heart. These extra-systoles must be timed correctly to achieve beneficial effects on myocardial mechanics (efficacy) while maintaining an extremely low level of risk of arrhythmia induction and excellent ICD-like arrhythmia sensing and detection (security). The present invention relates to therapy delivery guidance and options for improved ESS therapy delivery. These methods may be employed individually or in combinations in an external or implantable ESS therapy delivery device.

Claims

1. A method for managing an extra-systolic stimulation cardiac pacing therapy on a beat-by-beat basis, comprising:

sensing electrical activity of a heart on a beat-by-beat basis to provide output signals related to at least one of;

a sensed atrial depolarization, a first atrial pacing event, a second atrial pacing event, a sensed right ventricular depolarization, a first right ventricular pacing event, a second right ventricular pacing event, a sensed left ventricular depolarization, a first left ventricular pacing event, a second left ventricular pacing event;

determining if the output signals indicate an occurrence of at least one unscheduled depolarization in a single cardiac chamber; and

if at least one unscheduled depolarization occurred, then deciding between a mode of ceasing delivery and delivering an extra-systolic stimulation therapy to at least one chamber of the heart,

wherein the ceasing step further comprises one of;

withholding delivery and not initiating delivery of the extra-systolic stimulation therapy in the event that the unscheduled cardiac activity begins an accumulating tachycardia evidence counter of an on-going tachycardia episode or until such time as either the evidence counter reaches a preset threshold and a tachycardia episode is declared or the evidence counter is reset to a nominal or null value.

2. A method according to claim 1, wherein said at least one unscheduled depolarization comprises a premature atrial contraction or a premature ventricular contraction.

3. A method according to claim 1, wherein the accumulating tachycardia evidence counter collects evidence based only on ventricular events.

4. A method according to claim 3, wherein said ventricular events comprise right ventricular chamber events.

5. A method according to claim 3, wherein said ventricular events comprise right atrial chamber events.

6. A method according to claim 1, wherein the accumulating tachycardia evidence counter collects evidence based only on atrial events.

7. A method according to claim 6, further comprising:

in the event that an atrial tachycardia is detected, switching from a currently applied pacing therapy mode to a ventricular coupled pacing therapy mode.

8. A method according to claim 1, wherein the at least one unscheduled depolarization comprises two unscheduled depolarizations.

9. A method according to claim 8, further comprising:

searching to detect a fibrillation condition;

in the event that the fibrillation condition is detected either;

withholding delivery of the extra-systolic stimulation therapy, or

not initiating delivery of the extra-systolic stimulation therapy;

attempting to re-detect the fibrillation condition; and

in the event that the fibrillation condition is re-detected performing at least one of;

applying a cardioversion therapy to at least one chamber of the heart, and applying a defibrillation therapy to at least one chamber of the heart.

10. A method according to claim 9, wherein the at least one chamber of the heart comprises a ventricular chamber.

11. A method according to claim 9, further comprising:

discontinuing delivery of the extra-systolic therapy following the application of one of the cardioversion therapy and the defibrillation therapy.

12. A method according to claim 9, wherein the attempting to detect step further comprises:

deriving a parameter related to mechanical function of the heart; and

comparing the parameter to a known or a derived confirmatory fibrillation condition parameter.

13. A method according to claim 12, wherein the parameter related to mechanical function comprises at least one of:

a cardiac fluid pressure parameter, a rate of change of a cardiac fluid parameter, a mathematical integral of a cardiac fluid pressure parameter, a cardiac wall acceleration parameter, an apical acceleration parameter, a septal wall acceleration signal, a mid-basal left ventricular acceleration signal, an acoustic cardiac parameter, an impedance-based cardiac parameter.

14. A method according to claim 1, further comprising:

initiating a non-extra-systolic stimulation pacing modality.

15. A method according to claim 14, wherein the non-extra-systolic stimulation pacing modality includes at least one of the following pacing modalities:

a cardiac resynchronization pacing therapy, a single-chamber pacing therapy, a double-chamber pacing therapy, and a quadruple-chamber pacing therapy.

16. A medium according to claim 1, wherein the beat-by-beat basis comprises an extra-systolic interval and a post-extra-systolic interval and said post-extra-systolic interval exceeds said extra-systolic interval.

17. A medium according to claim 16, wherein any cardiac activity occurring during the extra-systolic interval qualifies as the at least one unscheduled depolarization.